Partnership focuses on compounds to protect against radiation exposure
Main Category: Bio-terrorism / TerrorismArticle Date: 27 May 2005 - 0:00 PDT
| Patient / Public: | ![]() |
1.36 (14 votes) |
| Healthcare Prof: | ![]() |
1.42 (33 votes) |
The Henry M Jackson Foundation for the Advancement of Military Medicine (HJF) has entered into an agreement with the Uniformed Services University of the Health Sciences (USU) and Humanetics Corporation to develop and commercialize nutritional supplements and drugs that show promise in boosting the immune system to protect against challenges from exposure to radiation. The primary aim of the program is to screen, develop and test compounds that could protect from dangerous radiation levels associated with a nuclear incident or terrorist attack. Operating through a unique Master Cooperative Research and Development Agreement (CRADA), USU is conducting the research program through the Armed Forces Radiobiology Research Institute (AFRRI) and the F. Edward Ebert School of Medicine. AFRRI is the nation's premier center for radiation injury countermeasure research.
AFRRI Director Col. David G. Jarrett, M.D. stated, "This project will allow expansion of our research. We believe that this program will accelerate the development of new ways to address radiation-related terrorism threats, and may provide a safe, cost-effective means of diminishing radiation injury for large numbers of people."
In July 2004, HJF, USU and Humanetics entered into their first CRADA to develop a nutritional supplement that will support immune system function. Under this agreement, AFRRI researchers are working with Humanetics to develop a compound to support immune function and to explore the potential benefits of the compound for military personnel. Military service members are often in situations that could present challenges to their immune systems, including chronic stress from psychological and environmental factors, military training and combat.
Recognizing the potential for nutritional supplements to strengthen immune function, AFRRI and Humanetics expanded their efforts by designing and implementing a unique joint research program within AFRRI to screen, develop and test several nutritional supplements that exhibit such potential. The Master CRADA, unlike a standard CRADA, is not limited to one compound, so it provides the flexibility to rapidly incorporate new candidate compounds into the research program.
In addition to roughly 10 million U.S. military service members and first responders, it is estimated that 90 million civilians in the top 10 metropolitan areas are considered potential victims of a terrorist attack. A nutritional supplement that can bolster the immune system against the harmful effects of radiation would be a significant step forward in efforts to protect both military personnel and civilians from terrorist attack.
The Henry M. Jackson Foundation for the Advancement of Military Medicine (http://www.hjf.org) is a private, not-for-profit organization chartered by Congress to support military medical research and education at the Uniformed Services University of the Health Sciences and throughout military medicine.
The Uniformed Services University of the Health Sciences (http://www.usuhs.mil) was chartered by the U.S. Congress and is a fully-accredited DoD graduate-education university.
Humanetics Corporation is a privately-held company headquartered in Minneapolis, Minnesota. Humanetics focuses on delivering proprietary, science-based and clinically-tested solutions to consumer health and aging concerns. For more information about Humanetics and its products, visit http://www.humaneticscorp.com.
Contact: Lisa Reilly
lreilly@hjf.org
301-294-1234
Henry M. Jackson Foundation for the Advancement of Military Medicine
http://www.hjf.org
Visit our bio-terrorism / terrorism section for the latest news on this subject.
MLA
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/25192.php>
APA
http://www.medicalnewstoday.com/releases/25192.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



